3,979 reports of this reaction
1.9% of all LEVETIRACETAM reports
#7 most reported adverse reaction
SOMNOLENCE is the #7 most commonly reported adverse reaction for LEVETIRACETAM, manufactured by UCB, Inc.. There are 3,979 FDA adverse event reports linking LEVETIRACETAM to SOMNOLENCE. This represents approximately 1.9% of all 207,510 adverse event reports for this drug.
Patients taking LEVETIRACETAM who experience somnolence should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SOMNOLENCE is a less commonly reported adverse event for LEVETIRACETAM, but still significant enough to appear in the safety profile.
In addition to somnolence, the following adverse reactions have been reported for LEVETIRACETAM:
The following drugs have also been linked to somnolence in FDA adverse event reports:
SOMNOLENCE has been reported as an adverse event in 3,979 FDA reports for LEVETIRACETAM. This does not prove causation, but indicates an association observed in post-market surveillance data.
SOMNOLENCE accounts for approximately 1.9% of all adverse event reports for LEVETIRACETAM, making it a notable side effect.
If you experience somnolence while taking LEVETIRACETAM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.